+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Blood & Plasma Components Market by Product Type, Application, End User, Distribution Channel - Global Forecast to 2030- Product Image
Blood & Plasma Components Market by Product Type, Application, End User, Distribution Channel - Global Forecast to 2030- Product Image
Sale

Blood & Plasma Components Market by Product Type, Application, End User, Distribution Channel - Global Forecast to 2030

  • PDF Icon

    Report

  • 180 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6010964
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Blood & Plasma Components Market grew from USD 45.86 billion in 2024 to USD 48.62 billion in 2025. It is expected to continue growing at a CAGR of 5.75%, reaching USD 64.15 billion by 2030.

Unveiling the Crucial Foundation of Blood and Plasma Components

The intricate world of blood and plasma components underpins critical healthcare operations, from life-saving transfusions to advanced therapeutic interventions. This executive summary distills the essential forces shaping this sector, offering decision-makers a concise yet profound understanding of market dynamics. Readers will uncover how evolving technologies, regulatory frameworks, and global demand patterns converge to create both challenges and opportunities. By presenting a clear overview of supply chains, stakeholder incentives, and emerging innovations, this summary establishes the strategic context necessary for informed investment and operational planning. As you progress through these insights, expect to engage with actionable analysis that bridges high-level trends and the granular drivers influencing every segment of this vital market.

Embracing Transformative Shifts in Blood and Plasma Supply Dynamics

Recent years have witnessed seismic shifts in the supply dynamics of blood and plasma components, propelled by technological breakthroughs and changing healthcare priorities. Advances in plasmapheresis techniques have enhanced yield and donor safety, while next-generation manufacturing platforms are streamlining the purification of coagulation factors and immunoglobulins. At the same time, heightened regulatory scrutiny around donor eligibility and pathogen reduction has introduced new compliance requirements, compelling organizations to adapt rapidly. The role of digital platforms in donor recruitment and supply chain tracking has grown exponentially, enabling real-time visibility and predictive analytics. Collectively, these trends are redrawing competitive boundaries, catalyzing partnerships between biopharmaceutical innovators and collection networks. By understanding how these transformative forces intersect, stakeholders can position themselves to capture value and drive sustainable growth in an increasingly complex landscape.

Assessing the Full Spectrum of United States Tariff Implications

The cumulative impact of newly implemented United States tariffs in 2025 has reverberated across the entire value chain of blood and plasma products. Incremental duties on imported reagents and collection systems have elevated production costs, prompting manufacturers to reassess sourcing strategies and negotiate volume agreements with domestic suppliers. Hospitals and laboratories have absorbed part of these increases, but pressure on reimbursement policies has intensified, introducing tighter budgetary constraints. Simultaneously, heightened import barriers have incentivized local innovation, spurring investments in homegrown plasma fractionation facilities and advanced filtration technologies. While some organizations have successfully mitigated tariff effects through vertical integration and strategic alliances, others face margin compression and supply bottlenecks. This duality underscores the importance of adaptive pricing models and proactive stakeholder engagement to navigate the evolving economic environment.

Unlocking Insights Through Comprehensive Market Segmentation

A multidimensional segmentation framework offers a granular view of market dynamics across diverse product types, applications, end users, and distribution pathways. Within product categories, plasma proteins constitute a core focus, encompassing albumin and specialized fractions such as coagulation factors and immunoglobulins; the latter further differentiates into intravenous and subcutaneous formulations. Beyond plasma, the segmentation extends to cellular elements including platelets, red blood cells, and white blood cells, each exhibiting unique collection and storage requirements. Application-based segmentation highlights distinct demand drivers in diagnostics, research environments, and therapeutic settings, where efficacy and safety standards vary. On the end-user front, requirements diverge across diagnostic laboratories, hospitals of all types-from ambulatory surgical centers to government and private institutions-and research organizations pursuing novel interventions. Finally, distribution channels span hospital pharmacies, emerging online platforms, and traditional retail outlets, reflecting the evolving pathways through which these vital products reach patients and practitioners. This holistic segmentation equips leaders with targeted intelligence to align resource allocation and product development roadmaps.

Mapping Regional Landscapes to Drive Strategic Focus

Regional landscapes reveal differentiated trajectories shaped by economic, regulatory, and infrastructure variables. In the Americas, robust donor networks and established fractionation facilities support a mature market, yet supply volatility persists amid shifting policy debates on donor compensation and plasma export. Across Europe, the Middle East and Africa, harmonization of regulatory frameworks underpins cross-border collaboration, while investments in emerging economies expand collection capacity. Countries within this region are balancing public-sector reliance with growing private-sector participation to alleviate shortages. Meanwhile, the Asia-Pacific zone demonstrates dynamic growth potential driven by expanding healthcare access and rising prevalence of chronic conditions requiring plasma-derived therapies. Local manufacturing initiatives, supported by government incentives, aim to reduce import dependency and foster technology transfer. By mapping these regional nuances, organizations can prioritize market entry strategies, tailor pricing models, and optimize distribution networks to capitalize on each geography’s unique characteristics.

Spotlight on Leading Innovators and Competitive Strategies

Leading companies within the blood and plasma domain are differentiating through a combination of technological innovation, strategic partnerships, and capacity expansion. Some global fractionators are pioneering next-generation purification processes to enhance yield and reduce production timelines, while others are investing in advanced analytics to forecast demand and streamline logistics. Collaborative alliances between biopharma firms and donor network operators are emerging as a means to secure reliable raw material supplies and accelerate clinical development pathways. At the same time, specialized start-ups are disrupting conventional models by introducing novel cell-based therapies and point-of-care diagnostic platforms that rely on bespoke blood components. Across the competitive landscape, emphasis on quality accreditation and regulatory compliance remains paramount, serving as a barrier to entry and a key differentiator for established players. This evolving ecosystem underscores the imperative for continuous innovation, agile manufacturing, and outcome-driven collaboration to maintain market leadership.

Delivering Actionable Recommendations to Propel Growth and Resilience

To thrive in this rapidly evolving environment, industry leaders should prioritize strategic investments in automation and digitalization across the supply chain to drive efficiency and transparency. Establishing or expanding domestic manufacturing capabilities can mitigate geopolitical and tariff-related risks, while forging partnerships with research institutions will accelerate innovation in novel therapeutics and diagnostics. Organizations must also engage proactively with regulators and payers to shape favorable policy frameworks and secure reimbursement pathways that reflect the true value of premium plasma-derived products. Additionally, tailoring distribution strategies to local market dynamics-leveraging online channels in urban centers and reinforcing hospital pharmacy networks in regions with established systems-will maximize patient reach. Finally, embedding sustainability initiatives in donor recruitment and waste management not only addresses ethical imperatives but also enhances brand reputation and long-term resilience. Executives who adopt these recommendations can transform challenges into opportunities and fortify their competitive advantage.

Framing a Robust Research Methodology for Credible Analysis

This analysis synthesizes primary interviews with industry executives, plasma collection specialists, and healthcare providers, complemented by secondary research from regulatory filings and peer-reviewed publications. Quantitative data on donation volumes, product output, and pricing trends were triangulated using proprietary databases and public sources to ensure robustness. The research process incorporated scenario modeling to evaluate the impact of tariff changes and regulatory reforms under various market conditions. A rigorous validation phase, involving external subject-matter experts, confirmed the accuracy and relevance of key insights. Throughout, methodological rigor was maintained by adhering to established best practices in market research, including standardized data cleaning, cross-verification protocols, and transparent documentation of assumptions. This comprehensive approach underlies the credibility of the findings and empowers decision-makers with confidence when formulating strategic initiatives.

Synthesizing Key Takeaways to Steer Executive Decision-Making

In synthesizing these insights, it becomes clear that blood and plasma markets are at a pivotal juncture defined by innovation, regulatory evolution, and shifting economic forces. Stakeholders who embrace advanced purification technologies, diversify geographic sourcing, and engage in cross-sector partnerships will be best positioned to navigate complexity and capture emerging opportunities. As tariff landscapes and healthcare imperatives continue to evolve, adaptability and foresight will differentiate market leaders from followers. The integrated segmentation, regional analysis, and competitive profiling presented here offer a roadmap for aligning investments with future demand patterns. Ultimately, success in this domain requires a harmonious balance of operational excellence, strategic agility, and a steadfast commitment to patient safety and quality outcomes.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Product Type
    • Plasma Proteins
      • Albumin
      • Coagulation Factors
        • Factor IX
        • Factor VIII
        • Prothrombin Complex Concentrates
      • Immunoglobulins
        • Intravenous Immunoglobulin
        • Subcutaneous Immunoglobulin
    • Platelets
    • Red Blood Cells
    • White Blood Cells
  • Application
    • Diagnostic
    • Research
    • Therapeutic
  • End User
    • Diagnostic Laboratories
    • Hospitals
      • Ambulatory Surgical Centers
      • Government Hospitals
      • Private Hospitals
    • Research Institutions
  • Distribution Channel
    • Hospital Pharmacies
    • Online Pharmacies
    • Retail Pharmacies
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
  • CSL Limited
  • Grifols, S.A.
  • Takeda Pharmaceutical Company Limited
  • Octapharma AG
  • Biotest AG
  • KEDRION S.p.A.
  • Shanghai RAAS Blood Products Co., Ltd
  • Bio Products Laboratory Limited
  • LFB S.A.
  • Sanquin Blood Supply Foundation

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Blood & Plasma Components Market, by Product Type
8.1. Introduction
8.2. Plasma Proteins
8.2.1. Albumin
8.2.2. Coagulation Factors
8.2.2.1. Factor IX
8.2.2.2. Factor VIII
8.2.2.3. Prothrombin Complex Concentrates
8.2.3. Immunoglobulins
8.2.3.1. Intravenous Immunoglobulin
8.2.3.2. Subcutaneous Immunoglobulin
8.3. Platelets
8.4. Red Blood Cells
8.5. White Blood Cells
9. Blood & Plasma Components Market, by Application
9.1. Introduction
9.2. Diagnostic
9.3. Research
9.4. Therapeutic
10. Blood & Plasma Components Market, by End User
10.1. Introduction
10.2. Diagnostic Laboratories
10.3. Hospitals
10.3.1. Ambulatory Surgical Centers
10.3.2. Government Hospitals
10.3.3. Private Hospitals
10.4. Research Institutions
11. Blood & Plasma Components Market, by Distribution Channel
11.1. Introduction
11.2. Hospital Pharmacies
11.3. Online Pharmacies
11.4. Retail Pharmacies
12. Americas Blood & Plasma Components Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Blood & Plasma Components Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Blood & Plasma Components Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. CSL Limited
15.3.2. Grifols, S.A.
15.3.3. Takeda Pharmaceutical Company Limited
15.3.4. Octapharma AG
15.3.5. Biotest AG
15.3.6. KEDRION S.p.A.
15.3.7. Shanghai RAAS Blood Products Co., Ltd
15.3.8. Bio Products Laboratory Limited
15.3.9. LFB S.A.
15.3.10. Sanquin Blood Supply Foundation
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. BLOOD & PLASMA COMPONENTS MARKET MULTI-CURRENCY
FIGURE 2. BLOOD & PLASMA COMPONENTS MARKET MULTI-LANGUAGE
FIGURE 3. BLOOD & PLASMA COMPONENTS MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 14. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS BLOOD & PLASMA COMPONENTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS BLOOD & PLASMA COMPONENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES BLOOD & PLASMA COMPONENTS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES BLOOD & PLASMA COMPONENTS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC BLOOD & PLASMA COMPONENTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC BLOOD & PLASMA COMPONENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. BLOOD & PLASMA COMPONENTS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. BLOOD & PLASMA COMPONENTS MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. BLOOD & PLASMA COMPONENTS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PLASMA PROTEINS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY ALBUMIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY COAGULATION FACTORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY FACTOR IX, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY FACTOR VIII, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PROTHROMBIN COMPLEX CONCENTRATES, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY COAGULATION FACTORS, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY IMMUNOGLOBULINS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY INTRAVENOUS IMMUNOGLOBULIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY SUBCUTANEOUS IMMUNOGLOBULIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY IMMUNOGLOBULINS, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PLASMA PROTEINS, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PLATELETS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY RED BLOOD CELLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY WHITE BLOOD CELLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY DIAGNOSTIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY RESEARCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY THERAPEUTIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY GOVERNMENT HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY RESEARCH INSTITUTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. AMERICAS BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 39. AMERICAS BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PLASMA PROTEINS, 2018-2030 (USD MILLION)
TABLE 40. AMERICAS BLOOD & PLASMA COMPONENTS MARKET SIZE, BY COAGULATION FACTORS, 2018-2030 (USD MILLION)
TABLE 41. AMERICAS BLOOD & PLASMA COMPONENTS MARKET SIZE, BY IMMUNOGLOBULINS, 2018-2030 (USD MILLION)
TABLE 42. AMERICAS BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 43. AMERICAS BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 44. AMERICAS BLOOD & PLASMA COMPONENTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 45. AMERICAS BLOOD & PLASMA COMPONENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 46. AMERICAS BLOOD & PLASMA COMPONENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 47. UNITED STATES BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 48. UNITED STATES BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PLASMA PROTEINS, 2018-2030 (USD MILLION)
TABLE 49. UNITED STATES BLOOD & PLASMA COMPONENTS MARKET SIZE, BY COAGULATION FACTORS, 2018-2030 (USD MILLION)
TABLE 50. UNITED STATES BLOOD & PLASMA COMPONENTS MARKET SIZE, BY IMMUNOGLOBULINS, 2018-2030 (USD MILLION)
TABLE 51. UNITED STATES BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 52. UNITED STATES BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 53. UNITED STATES BLOOD & PLASMA COMPONENTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 54. UNITED STATES BLOOD & PLASMA COMPONENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 55. UNITED STATES BLOOD & PLASMA COMPONENTS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 56. CANADA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 57. CANADA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PLASMA PROTEINS, 2018-2030 (USD MILLION)
TABLE 58. CANADA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY COAGULATION FACTORS, 2018-2030 (USD MILLION)
TABLE 59. CANADA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY IMMUNOGLOBULINS, 2018-2030 (USD MILLION)
TABLE 60. CANADA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 61. CANADA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 62. CANADA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 63. CANADA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 64. MEXICO BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 65. MEXICO BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PLASMA PROTEINS, 2018-2030 (USD MILLION)
TABLE 66. MEXICO BLOOD & PLASMA COMPONENTS MARKET SIZE, BY COAGULATION FACTORS, 2018-2030 (USD MILLION)
TABLE 67. MEXICO BLOOD & PLASMA COMPONENTS MARKET SIZE, BY IMMUNOGLOBULINS, 2018-2030 (USD MILLION)
TABLE 68. MEXICO BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 69. MEXICO BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 70. MEXICO BLOOD & PLASMA COMPONENTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 71. MEXICO BLOOD & PLASMA COMPONENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 72. BRAZIL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 73. BRAZIL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PLASMA PROTEINS, 2018-2030 (USD MILLION)
TABLE 74. BRAZIL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY COAGULATION FACTORS, 2018-2030 (USD MILLION)
TABLE 75. BRAZIL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY IMMUNOGLOBULINS, 2018-2030 (USD MILLION)
TABLE 76. BRAZIL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 77. BRAZIL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 78. BRAZIL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 79. BRAZIL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 80. ARGENTINA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 81. ARGENTINA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PLASMA PROTEINS, 2018-2030 (USD MILLION)
TABLE 82. ARGENTINA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY COAGULATION FACTORS, 2018-2030 (USD MILLION)
TABLE 83. ARGENTINA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY IMMUNOGLOBULINS, 2018-2030 (USD MILLION)
TABLE 84. ARGENTINA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 85. ARGENTINA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 86. ARGENTINA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 87. ARGENTINA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 88. EUROPE, MIDDLE EAST & AFRICA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 89. EUROPE, MIDDLE EAST & AFRICA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PLASMA PROTEINS, 2018-2030 (USD MILLION)
TABLE 90. EUROPE, MIDDLE EAST & AFRICA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY COAGULATION FACTORS, 2018-2030 (USD MILLION)
TABLE 91. EUROPE, MIDDLE EAST & AFRICA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY IMMUNOGLOBULINS, 2018-2030 (USD MILLION)
TABLE 92. EUROPE, MIDDLE EAST & AFRICA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 93. EUROPE, MIDDLE EAST & AFRICA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 94. EUROPE, MIDDLE EAST & AFRICA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 95. EUROPE, MIDDLE EAST & AFRICA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 96. EUROPE, MIDDLE EAST & AFRICA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 97. UNITED KINGDOM BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 98. UNITED KINGDOM BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PLASMA PROTEINS, 2018-2030 (USD MILLION)
TABLE 99. UNITED KINGDOM BLOOD & PLASMA COMPONENTS MARKET SIZE, BY COAGULATION FACTORS, 2018-2030 (USD MILLION)
TABLE 100. UNITED KINGDOM BLOOD & PLASMA COMPONENTS MARKET SIZE, BY IMMUNOGLOBULINS, 2018-2030 (USD MILLION)
TABLE 101. UNITED KINGDOM BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 102. UNITED KINGDOM BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 103. UNITED KINGDOM BLOOD & PLASMA COMPONENTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 104. UNITED KINGDOM BLOOD & PLASMA COMPONENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 105. GERMANY BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 106. GERMANY BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PLASMA PROTEINS, 2018-2030 (USD MILLION)
TABLE 107. GERMANY BLOOD & PLASMA COMPONENTS MARKET SIZE, BY COAGULATION FACTORS, 2018-2030 (USD MILLION)
TABLE 108. GERMANY BLOOD & PLASMA COMPONENTS MARKET SIZE, BY IMMUNOGLOBULINS, 2018-2030 (USD MILLION)
TABLE 109. GERMANY BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 110. GERMANY BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 111. GERMANY BLOOD & PLASMA COMPONENTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 112. GERMANY BLOOD & PLASMA COMPONENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 113. FRANCE BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 114. FRANCE BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PLASMA PROTEINS, 2018-2030 (USD MILLION)
TABLE 115. FRANCE BLOOD & PLASMA COMPONENTS MARKET SIZE, BY COAGULATION FACTORS, 2018-2030 (USD MILLION)
TABLE 116. FRANCE BLOOD & PLASMA COMPONENTS MARKET SIZE, BY IMMUNOGLOBULINS, 2018-2030 (USD MILLION)
TABLE 117. FRANCE BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 118. FRANCE BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 119. FRANCE BLOOD & PLASMA COMPONENTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 120. FRANCE BLOOD & PLASMA COMPONENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 121. RUSSIA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 122. RUSSIA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PLASMA PROTEINS, 2018-2030 (USD MILLION)
TABLE 123. RUSSIA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY COAGULATION FACTORS, 2018-2030 (USD MILLION)
TABLE 124. RUSSIA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY IMMUNOGLOBULINS, 2018-2030 (USD MILLION)
TABLE 125. RUSSIA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 126. RUSSIA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 127. RUSSIA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 128. RUSSIA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 129. ITALY BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 130. ITALY BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PLASMA PROTEINS, 2018-2030 (USD MILLION)
TABLE 131. ITALY BLOOD & PLASMA COMPONENTS MARKET SIZE, BY COAGULATION FACTORS, 2018-2030 (USD MILLION)
TABLE 132. ITALY BLOOD & PLASMA COMPONENTS MARKET SIZE, BY IMMUNOGLOBULINS, 2018-2030 (USD MILLION)
TABLE 133. ITALY BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 134. ITALY BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 135. ITALY BLOOD & PLASMA COMPONENTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 136. ITALY BLOOD & PLASMA COMPONENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 137. SPAIN BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 138. SPAIN BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PLASMA PROTEINS, 2018-2030 (USD MILLION)
TABLE 139. SPAIN BLOOD & PLASMA COMPONENTS MARKET SIZE, BY COAGULATION FACTORS, 2018-2030 (USD MILLION)
TABLE 140. SPAIN BLOOD & PLASMA COMPONENTS MARKET SIZE, BY IMMUNOGLOBULINS, 2018-2030 (USD MILLION)
TABLE 141. SPAIN BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 142. SPAIN BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 143. SPAIN BLOOD & PLASMA COMPONENTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 144. SPAIN BLOOD & PLASMA COMPONENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 145. UNITED ARAB EMIRATES BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 146. UNITED ARAB EMIRATES BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PLASMA PROTEINS, 2018-2030 (USD MILLION)
TABLE 147. UNITED ARAB EMIRATES BLOOD & PLASMA COMPONENTS MARKET SIZE, BY COAGULATION FACTORS, 2018-2030 (USD MILLION)
TABLE 148. UNITED ARAB EMIRATES BLOOD & PLASMA COMPONENTS MARKET SIZE, BY IMMUNOGLOBULINS, 2018-2030 (USD MILLION)
TABLE 149. UNITED ARAB EMIRATES BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 150. UNITED ARAB EMIRATES BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 151. UNITED ARAB EMIRATES BLOOD & PLASMA COMPONENTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 152. UNITED ARAB EMIRATES BLOOD & PLASMA COMPONENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 153. SAUDI ARABIA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 154. SAUDI ARABIA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PLASMA PROTEINS, 2018-2030 (USD MILLION)
TABLE 155. SAUDI ARABIA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY COAGULATION FACTORS, 2018-2030 (USD MILLION)
TABLE 156. SAUDI ARABIA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY IMMUNOGLOBULINS, 2018-2030 (USD MILLION)
TABLE 157. SAUDI ARABIA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 158. SAUDI ARABIA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 159. SAUDI ARABIA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 160. SAUDI ARABIA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 161. SOUTH AFRICA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 162. SOUTH AFRICA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PLASMA PROTEINS, 2018-2030 (USD MILLION)
TABLE 163. SOUTH AFRICA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY COAGULATION FACTORS, 2018-2030 (USD MILLION)
TABLE 164. SOUTH AFRICA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY IMMUNOGLOBULINS, 2018-2030 (USD MILLION)
TABLE 165. SOUTH AFRICA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 166. SOUTH AFRICA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 167. SOUTH AFRICA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 168. SOUTH AFRICA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 169. DENMARK BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 170. DENMARK BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PLASMA PROTEINS, 2018-2030 (USD MILLION)
TABLE 171. DENMARK BLOOD & PLASMA COMPONENTS MARKET SIZE, BY COAGULATION FACTORS, 2018-2030 (USD MILLION)
TABLE 172. DENMARK BLOOD & PLASMA COMPONENTS MARKET SIZE, BY IMMUNOGLOBULINS, 2018-2030 (USD MILLION)
TABLE 173. DENMARK BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 174. DENMARK BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 175. DENMARK BLOOD & PLASMA COMPONENTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 176. DENMARK BLOOD & PLASMA COMPONENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 177. NETHERLANDS BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 178. NETHERLANDS BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PLASMA PROTEINS, 2018-2030 (USD MILLION)
TABLE 179. NETHERLANDS BLOOD & PLASMA COMPONENTS MARKET SIZE, BY COAGULATION FACTORS, 2018-2030 (USD MILLION)
TABLE 180. NETHERLANDS BLOOD & PLASMA COMPONENTS MARKET SIZE, BY IMMUNOGLOBULINS, 2018-2030 (USD MILLION)
TABLE 181. NETHERLANDS BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 182. NETHERLANDS BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 183. NETHERLANDS BLOOD & PLASMA COMPONENTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 184. NETHERLANDS BLOOD & PLASMA COMPONENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 185. QATAR BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 186. QATAR BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PLASMA PROTEINS, 2018-2030 (USD MILLION)
TABLE 187. QATAR BLOOD & PLASMA COMPONENTS MARKET SIZE, BY COAGULATION FACTORS, 2018-2030 (USD MILLION)
TABLE 188. QATAR BLOOD & PLASMA COMPONENTS MARKET SIZE, BY IMMUNOGLOBULINS, 2018-2030 (USD MILLION)
TABLE 189. QATAR BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 190. QATAR BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 191. QATAR BLOOD & PLASMA COMPONENTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 192. QATAR BLOOD & PLASMA COMPONENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 193. FINLAND BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 194. FINLAND BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PLASMA PROTEINS, 2018-2030 (USD MILLION)
TABLE 195. FINLAND BLOOD & PLASMA COMPONENTS MARKET SIZE, BY COAGULATION FACTORS, 2018-2030 (USD MILLION)
TABLE 196. FINLAND BLOOD & PLASMA COMPONENTS MARKET SIZE, BY IMMUNOGLOBULINS, 2018-2030 (USD MILLION)
TABLE 197. FINLAND BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 198. FINLAND BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 199. FINLAND BLOOD & PLASMA COMPONENTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 200. FINLAND BLOOD & PLASMA COMPONENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 201. SWEDEN BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 202. SWEDEN BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PLASMA PROTEINS, 2018-2030 (USD MILLION)
TABLE 203. SWEDEN BLOOD & PLASMA COMPONENTS MARKET SIZE, BY COAGULATION FACTORS, 2018-2030 (USD MILLION)
TABLE 204. SWEDEN BLOOD & PLASMA COMPONENTS MARKET SIZE, BY IMMUNOGLOBULINS, 2018-2030 (USD MILLION)
TABLE 205. SWEDEN BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 206. SWEDEN BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 207. SWEDEN BLOOD & PLASMA COMPONENTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 208. SWEDEN BLOOD & PLASMA COMPONENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 209. NIGERIA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 210. NIGERIA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PLASMA PROTEINS, 2018-2030 (USD MILLION)
TABLE 211. NIGERIA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY COAGULATION FACTORS, 2018-2030 (USD MILLION)
TABLE 212. NIGERIA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY IMMUNOGLOBULINS, 2018-2030 (USD MILLION)
TABLE 213. NIGERIA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 214. NIGERIA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 215. NIGERIA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 216. NIGERIA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 217. EGYPT BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 218. EGYPT BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PLASMA PROTEINS, 2018-2030 (USD MILLION)
TABLE 219. EGYPT BLOOD & PLASMA COMPONENTS MARKET SIZE, BY COAGULATION FACTORS, 2018-2030 (USD MILLION)
TABLE 220. EGYPT BLOOD & PLASMA COMPONENTS MARKET SIZE, BY IMMUNOGLOBULINS, 2018-2030 (USD MILLION)
TABLE 221. EGYPT BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 222. EGYPT BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 223. EGYPT BLOOD & PLASMA COMPONENTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 224. EGYPT BLOOD & PLASMA COMPONENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 225. TURKEY BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 226. TURKEY BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PLASMA PROTEINS, 2018-2030 (USD MILLION)
TABLE 227. TURKEY BLOOD & PLASMA COMPONENTS MARKET SIZE, BY COAGULATION FACTORS, 2018-2030 (USD MILLION)
TABLE 228. TURKEY BLOOD & PLASMA COMPONENTS MARKET SIZE, BY IMMUNOGLOBULINS, 2018-2030 (USD MILLION)
TABLE 229. TURKEY BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 230. TURKEY BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 231. TURKEY BLOOD & PLASMA COMPONENTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 232. TURKEY BLOOD & PLASMA COMPONENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 233. ISRAEL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 234. ISRAEL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PLASMA PROTEINS, 2018-2030 (USD MILLION)
TABLE 235. ISRAEL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY COAGULATION FACTORS, 2018-2030 (USD MILLION)
TABLE 236. ISRAEL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY IMMUNOGLOBULINS, 2018-2030 (USD MILLION)
TABLE 237. ISRAEL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 238. ISRAEL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 239. ISRAEL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 240. ISRAEL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 241. NORWAY BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 242. NORWAY BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PLASMA PROTEINS, 2018-2030 (USD MILLION)
TABLE 243. NORWAY BLOOD & PLASMA COMPONENTS MARKET SIZE, BY COAGULATION FACTORS, 2018-2030 (USD MILLION)
TABLE 244. NORWAY BLOOD & PLASMA COMPONENTS MARKET SIZE, BY IMMUNOGLOBULINS, 2018-2030 (USD MILLION)
TABLE 245. NORWAY BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 246. NORWAY BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 247. NORWAY BLOOD & PLASMA COMPONENTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 248. NORWAY BLOOD & PLASMA COMPONENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 249. POLAND BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 250. POLAND BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PLASMA PROTEINS, 2018-2030 (USD MILLION)
TABLE 251. POLAND BLOOD & PLASMA COMPONENTS MARKET SIZE, BY COAGULATION FACTORS, 2018-2030 (USD MILLION)
TABLE 252. POLAND BLOOD & PLASMA COMPONENTS MARKET SIZE, BY IMMUNOGLOBULINS, 2018-2030 (USD MILLION)
TABLE 253. POLAND BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 254. POLAND BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 255. POLAND BLOOD & PLASMA COMPONENTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 256. POLAND BLOOD & PLASMA COMPONENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 257. SWITZERLAND BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 258. SWITZERLAND BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PLASMA PROTEINS, 2018-2030 (USD MILLION)
TABLE 259. SWITZERLAND BLOOD & PLASMA COMPONENTS MARKET SIZE, BY COAGULATION FACTORS, 2018-2030 (USD MILLION)
TABLE 260. SWITZERLAND BLOOD & PLASMA COMPONENTS MARKET SIZE, BY IMMUNOGLOBULINS, 2018-2030 (USD MILLION)
TABLE 261. SWITZERLAND BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 262. SWITZERLAND BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 263. SWITZERLAND BLOOD & PLASMA COMPONENTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 264. SWITZERLAND BLOOD & PLASMA COMPONENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 265. ASIA-PACIFIC BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 266. ASIA-PACIFIC BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PLASMA PROTEINS, 2018-2030 (USD MILLION)
TABLE 267. ASIA-PACIFIC BLOOD & PLASMA COMPONENTS MARKET SIZE, BY COAGULATION FACTORS, 2018-2030 (USD MILLION)
TABLE 268. ASIA-PACIFIC BLOOD & PLASMA COMPONENTS MARKET SIZE, BY IMMUNOGLOBULINS, 2018-2030 (USD MILLION)
TABLE 269. ASIA-PACIFIC BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 270. ASIA-PACIFIC BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 271. ASIA-PACIFIC BLOOD & PLASMA COMPONENTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 272. ASIA-PACIFIC BLOOD & PLASMA COMPONENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 273. ASIA-PACIFIC BLOOD & PLASMA COMPONENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 274. CHINA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 275. CHINA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PLASMA PROTEINS, 2018-2030 (USD MILLION)
TABLE 276. CHINA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY COAGULATION FACTORS, 2018-2030 (USD MILLION)
TABLE 277. CHINA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY IMMUNOGLOBULINS, 2018-2030 (USD MILLION)
TABLE 278. CHINA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 279. CHINA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 280. CHINA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 281. CHINA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 282. INDIA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 283. INDIA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PLASMA PROTEINS, 2018-2030 (USD MILLION)
TABLE 284. INDIA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY COAGULATION FACTORS, 2018-2030 (USD MILLION)
TABLE 285. INDIA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY IMMUNOGLOBULINS, 2018-2030 (USD MILLION)
TABLE 286. INDIA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 287. INDIA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 288. INDIA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 289. INDIA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 290. JAPAN BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 291. JAPAN BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PLASMA PROTEINS, 2018-2030 (USD MILLION)
TABLE 292. JAPAN BLOOD & PLASMA COMPONENTS MARKET SIZE, BY COAGULATION FACTORS, 2018-2030 (USD MILLION)
TABLE 293. JAPAN BLOOD & PLASMA COMPONENTS MARKET SIZE, BY IMMUNOGLOBULINS, 2018-2030 (USD MILLION)
TABLE 294. JAPAN BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 295. JAPAN BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 296. JAPAN BLOOD & PLASMA COMPONENTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 297. JAPAN BLOOD & PLASMA COMPONENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 298. AUSTRALIA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 299. AUSTRALIA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PLASMA PROTEINS, 2018-2030 (USD MILLION)
TABLE 300. AUSTRALIA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY COAGULATION FACTORS, 2018-2030 (USD MILLION)
TABLE 301. AUSTRALIA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY IMMUNOGLOBULINS, 2018-2030 (USD MILLION)
TABLE 302. AUSTRALIA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 303. AUSTRALIA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 304. AUSTRALIA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 305. AUSTRALIA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 306. SOUTH KOREA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 307. SOUTH KOREA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PLASMA PROTEINS, 2018-2030 (USD MILLION)
TABLE 308. SOUTH KOREA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY COAGULATION FACTORS, 2018-2030 (USD MILLION)
TABLE 309. SOUTH KOREA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY IMMUNOGLOBULINS, 2018-2030 (USD MILLION)
TABLE 310. SOUTH KOREA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 311. SOUTH KOREA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 312. SOUTH KOREA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 313. SOUTH KOREA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 314. INDONESIA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 315. INDONESIA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PLASMA PROTEINS, 2018-2030 (USD MILLION)
TABLE 316. INDONESIA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY COAGULATION FACTORS, 2018-2030 (USD MILLION)
TABLE 317. INDONESIA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY IMMUNOGLOBULINS, 2018-2030 (USD MILLION)
TABLE 318. INDONESIA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 319. INDONESIA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 320. INDONESIA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 321. INDONESIA BLOOD

Companies Mentioned

The companies profiled in this Blood & Plasma Components market report include:
  • CSL Limited
  • Grifols, S.A.
  • Takeda Pharmaceutical Company Limited
  • Octapharma AG
  • Biotest AG
  • KEDRION S.p.A.
  • Shanghai RAAS Blood Products Co., Ltd
  • Bio Products Laboratory Limited
  • LFB S.A.
  • Sanquin Blood Supply Foundation

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages180
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 48.62 Billion
Forecasted Market Value ( USD ) by 2030 $ 64.15 Billion
Compound Annual Growth Rate5.7%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Blood Transfusion Devices Market by Product, Application, End User, Component, Mode, Distribution Channel, Technology - Global Forecast to 2030 - Product Image

Blood Transfusion Devices Market by Product, Application, End User, Component, Mode, Distribution Channel, Technology - Global Forecast to 2030

  • Report
  • 188 Pages
  • Global
From
Blood Banking & Blood Products Market by Product Type, Application, End User, Technology - Global Forecast to 2030 - Product Image

Blood Banking & Blood Products Market by Product Type, Application, End User, Technology - Global Forecast to 2030

  • Report
  • 191 Pages
  • Global
From
Blood Bank And Plasma Freezer Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Blood Bank And Plasma Freezer Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 182 Pages
  • Global
From
Blood Plasma Freezer Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Blood Plasma Freezer Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 182 Pages
  • Global
From
Plasma Fractionation Market Size, Share & Trends Analysis Report By Product (Immunoglobulins, Coagulation Factors), By Method (Chromatography, Centrifugation), By Application, By End-use, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Plasma Fractionation Market Size, Share & Trends Analysis Report By Product (Immunoglobulins, Coagulation Factors), By Method (Chromatography, Centrifugation), By Application, By End-use, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 120 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.